| Dr Richard Moscarelli, MD | |
|
2 Church St S, #209, New Haven, CT 06519-1717 | |
| (203) 787-2264 | |
| (203) 497-9354 |
| Full Name | Dr Richard Moscarelli |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 30 Years |
| Location | 2 Church St S, New Haven, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104855543 | NPI | - | NPPES |
| 0013667095 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 036709 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Yale-new Haven Hospital | New haven, CT | Hospital |
| Bridgeport Hospital | Bridgeport, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Yale University | 9436061736 | 2241 |
News Archive
As a general rule, your DNA is not something you want rearranged. But there are exceptions - especially when it comes to fighting infections. Since the number of microbes in the world far surpasses the amount of human DNA dedicated to combat them, specialized cells in the immune system have adopted an ingenious, if potentially disastrous, strategy for making antibodies. These cells, called B lymphocytes, intentionally mutate their own DNA to ward off invaders they have never seen before.
Adocia announces today positive preliminary results for the first clinical trial on an innovative formulation combining insulin analog Glargine (Lantus, Sanofi), the gold standard basal insulin, with a rapid-acting insulin analog, Lispro (Humalog, Eli Lilly) using Adocia's BioChaperone technology.
VisEn Medical Inc., a leader in fluorescence imaging solutions from research through medicine, announced today that it has expanded its leading FMT imaging platform with an FMT™ Multi-Species Imaging Module, to extend FMT imaging and related applications into larger preclinical animal models. VisEn also announced that it will be presenting new study results from its recently-launched Cat B 750 FAST™ and Annexin-Vivo™ fluorescence imaging agents at the AACR 101st Annual Meeting.
"With much of the global economy facing slowing growth and uncertain prospects, especially in developed countries, a new World Bank report" - titled "The Fiscal Dimension of HIV/AIDS in Botswana, South Africa, Swaziland, and Uganda" - "urges African governments and their development aid donors to do significantly more to prevent new HIV infections" and "warns that current spending on HIV/AIDS relates to past infections and is a potentially misleading indicator of the long-term public cost of the fight against HIV/AIDS," a World Bank press release states.
Brazil is expanding its national HIV/AIDS treatment program to include about 35,000 additional people, the Associated Press/Seattle Times reports. "Ronaldo Hallal of the health ministry's Sexually Transmitted Disease Department said people with 500 or fewer CD4 cells per cubic millimeter will receive antiretroviral HIV treatment," increasing the cutoff from 350 or less CD4 cells per cubic millimeter prior to the expansion, the news service writes.
› Verified 1 days ago
| Entity Name | Yale University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205822236 PECOS PAC ID: 9436061736 Enrollment ID: O20031105000015 |
News Archive
As a general rule, your DNA is not something you want rearranged. But there are exceptions - especially when it comes to fighting infections. Since the number of microbes in the world far surpasses the amount of human DNA dedicated to combat them, specialized cells in the immune system have adopted an ingenious, if potentially disastrous, strategy for making antibodies. These cells, called B lymphocytes, intentionally mutate their own DNA to ward off invaders they have never seen before.
Adocia announces today positive preliminary results for the first clinical trial on an innovative formulation combining insulin analog Glargine (Lantus, Sanofi), the gold standard basal insulin, with a rapid-acting insulin analog, Lispro (Humalog, Eli Lilly) using Adocia's BioChaperone technology.
VisEn Medical Inc., a leader in fluorescence imaging solutions from research through medicine, announced today that it has expanded its leading FMT imaging platform with an FMT™ Multi-Species Imaging Module, to extend FMT imaging and related applications into larger preclinical animal models. VisEn also announced that it will be presenting new study results from its recently-launched Cat B 750 FAST™ and Annexin-Vivo™ fluorescence imaging agents at the AACR 101st Annual Meeting.
"With much of the global economy facing slowing growth and uncertain prospects, especially in developed countries, a new World Bank report" - titled "The Fiscal Dimension of HIV/AIDS in Botswana, South Africa, Swaziland, and Uganda" - "urges African governments and their development aid donors to do significantly more to prevent new HIV infections" and "warns that current spending on HIV/AIDS relates to past infections and is a potentially misleading indicator of the long-term public cost of the fight against HIV/AIDS," a World Bank press release states.
Brazil is expanding its national HIV/AIDS treatment program to include about 35,000 additional people, the Associated Press/Seattle Times reports. "Ronaldo Hallal of the health ministry's Sexually Transmitted Disease Department said people with 500 or fewer CD4 cells per cubic millimeter will receive antiretroviral HIV treatment," increasing the cutoff from 350 or less CD4 cells per cubic millimeter prior to the expansion, the news service writes.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard Moscarelli, MD 2 Church St S, #209, New Haven, CT 06519-1717 Ph: (203) 787-2264 | Dr Richard Moscarelli, MD 2 Church St S, #209, New Haven, CT 06519-1717 Ph: (203) 787-2264 |
News Archive
As a general rule, your DNA is not something you want rearranged. But there are exceptions - especially when it comes to fighting infections. Since the number of microbes in the world far surpasses the amount of human DNA dedicated to combat them, specialized cells in the immune system have adopted an ingenious, if potentially disastrous, strategy for making antibodies. These cells, called B lymphocytes, intentionally mutate their own DNA to ward off invaders they have never seen before.
Adocia announces today positive preliminary results for the first clinical trial on an innovative formulation combining insulin analog Glargine (Lantus, Sanofi), the gold standard basal insulin, with a rapid-acting insulin analog, Lispro (Humalog, Eli Lilly) using Adocia's BioChaperone technology.
VisEn Medical Inc., a leader in fluorescence imaging solutions from research through medicine, announced today that it has expanded its leading FMT imaging platform with an FMT™ Multi-Species Imaging Module, to extend FMT imaging and related applications into larger preclinical animal models. VisEn also announced that it will be presenting new study results from its recently-launched Cat B 750 FAST™ and Annexin-Vivo™ fluorescence imaging agents at the AACR 101st Annual Meeting.
"With much of the global economy facing slowing growth and uncertain prospects, especially in developed countries, a new World Bank report" - titled "The Fiscal Dimension of HIV/AIDS in Botswana, South Africa, Swaziland, and Uganda" - "urges African governments and their development aid donors to do significantly more to prevent new HIV infections" and "warns that current spending on HIV/AIDS relates to past infections and is a potentially misleading indicator of the long-term public cost of the fight against HIV/AIDS," a World Bank press release states.
Brazil is expanding its national HIV/AIDS treatment program to include about 35,000 additional people, the Associated Press/Seattle Times reports. "Ronaldo Hallal of the health ministry's Sexually Transmitted Disease Department said people with 500 or fewer CD4 cells per cubic millimeter will receive antiretroviral HIV treatment," increasing the cutoff from 350 or less CD4 cells per cubic millimeter prior to the expansion, the news service writes.
› Verified 1 days ago
Chanhee Han, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 333 Cedar St # 328, New Haven, CT 06510 Phone: 203-785-7385 Fax: 203-737-4377 | |
Mary M Tse, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 136 Sherman Ave, Ste 301, New Haven, CT 06511 Phone: 203-776-7458 Fax: 203-776-2401 | |
Sallis O Yip, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 310 Cedar St # St329, New Haven, CT 06510 Phone: 203-785-6927 | |
J Ryan Martin, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 150 Sargent Dr, New Haven, CT 06511 Phone: 203-785-2140 Fax: 203-785-3419 | |
Peter E Schwartz, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 800 Howard Ave, Yale Physicians' Building, 3rd Floor, New Haven, CT 06519 Phone: 203-785-4176 Fax: 203-785-5886 | |
Dr. Denise Tonzola, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2 Church St S, #209, New Haven, CT 06519 Phone: 203-787-2264 Fax: 203-497-9354 | |
Dr. David P Fox, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 55 Lock Street, New Haven, CT 06520 Phone: 203-432-0076 Fax: 203-432-7289 |